Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Among approved drugs, tirzepatide (Mounjaro/Zepbound) produced the largest average weight loss in trials, about 20.9% over 72 weeks at the highest dose in SURMOUNT-1, ahead of semaglutide at roughly 14.9% over 68 weeks in STEP 1
53 However, in a 96-week phase 3 trial (n=194) of once-weekly exenatide 2 mg in people with moderately severe Parkinsons disease (without diabetes), there was no significant improvement in Parkinsons disease severity compared with placebo
0 No products in the cart
52-Week Range $623.78 $1,249.45 Dividend Yield 0.60% P/E Ratio 40.83 Price Target $1,283.64 The worlds largest pharmaceutical stock, Eli Lilly and Company NYSE: LLY, is back in the green in 2025 as of the Apr
The most common and severe form of extrapulmonary TB is TB meningitis, causing pronounced morbidity and mortality
US$ 29.48
US$ 23.15
US$ 22.29
US$ 23.98
US$ 20.85
US$ 25.22
US$ 28.96
US$ 22.84
